---
Free space for your campaign:
Order

Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Marlena (Anonymous, 37.225.34.) Polska 13 months ago

Which RSV vaccine is better for senior - Abrysvo whether Arexvy?

Which RSV vaccine is better for seniors - Abrysvo or Arexva?

4 answers

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Suggested Products

Space for your product

Your product would fit here?
Your product would fit here?

Set up a sponsored products campaign yourself:

Check
Angelika Talar-Śpionek

Angelika Talar-Śpionek Pharmacist, Editor

7 months ago

RSV vaccines contain the virus's recombinant F protein, which stimulates the immune system to produce antibodies without causing infection. Both are safe for seniors. In addition, both vaccines have been reimbursed since October 1, 2025.

Any adult can get vaccinated at a pharmacy and the service is free of charge.

Abrysvo is free of charge for pregnant women and seniors over 65 years of age. Reimbursed for people over 60 years of age (price PLN 408.86), and for adults under 60 years of age - fully paid (price PLN 817.72).

Arexvy is free for seniors from 65 years of age, reimbursed for people between 60 and 65 years of age (price 408.86 PLN) and fully paid for people between 50 and 60 years of age (price 817.72 PLN). This vaccine is not used in pregnant women and people under 50 years of age.

Therefore, seniors can get vaccinated for free in pharmacies, all they need is a PESEL number.

In both cases, taking one dose of the vaccine is enough to achieve immunity.

Here you can check which pharmacies administer the RSV vaccine and sign up for vaccination:

https://www.gdziepolek.pl/apteki/szczepiace-przeciw-rsv

Katarzyna Chadryś

Katarzyna Chadryś Pharmacist, Editor

7 months ago

Up to @muniek:

According to the current reimbursement list, effective from 1 October 2025, both vaccines are reimbursed. More information here:

https://www.gdziepolek.pl/produkty/121726/arexvy-iniekcja/refundacja

https://www.gdziepolek.pl/produkty/126177/abrysvo-iniekcja/refundacja

On the medication websites, you can check the availability in pharmacies and make a reservation.

muniek (Anonymous, 136.226.198.) 7 months ago

Is there really only one reimbursed?

Angelika Talar-Śpionek

Angelika Talar-Śpionek Pharmacist, Editor

13 months ago

Both vaccines show similar effectiveness, but only one of them is on the current list of reimbursed drugs.

Abrysvo is intended for all people over 18 years of age and pregnant women between 24 and 36 weeks of pregnancy. In order to achieve immunity, 1 dose of the vaccine is sufficient.
Abrysvo is on the list of reimbursed drugs. It is free of charge for pregnant women and seniors over 65 years of age. Reimbursed for people over 60 years of age (price PLN 408.86), and for adults under 60 years of age - fully paid (price PLN 817.72).

The second available vaccine is Arexvy. It is indicated for adults aged 50 to 59 years with an increased risk of developing the disease caused by RSV and adults aged 60 and older. It is not a preparation for pregnant women and people under 50 years of age. The Arexvy vaccine is non-refundable. Depending on the pharmacy, it costs from PLN 880 to PLN 1300 per dose. In order to achieve immunity, it is enough to take 1 dose of the vaccine.

Here you can check the availability of these vaccines in pharmacies and make a reservation:

https://www.gdziepolek.pl/produkty/126177/abrysvo-iniekcja/apteki

https://www.gdziepolek.pl/produkty/121726/arexvy-iniekcja/apteki

I've attached links to helpful entries:

https://www.gdziepolek.pl/substancje/szczepionka-przeciw-rsv

https://www.gdziepolek.pl/artykuly/rsv-zagraza-seniorom-oraz-niemowletom-szczepionka

User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists